Loading clinical trials...
Loading clinical trials...
A Double-blind, Randomized, Placebo-controlled Phase 2b Study to Establish the Effective Dose Range and to Evaluate the Safety of Chrysalin in Adult Subjects With a Fractured Distal Radius
Conditions
Interventions
Chrysalin
Chrysalin
+3 more
Locations
1
United States
OrthoLogic
Tempe, Arizona, United States
Start Date
November 1, 2004
Primary Completion Date
March 1, 2007
Completion Date
March 1, 2007
Last Updated
August 24, 2010
NCT05650996
NCT06678438
NCT06913920
NCT06857110
NCT06453447
NCT06078371
Lead Sponsor
Capstone Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions